CROs in Front Long-term investment The Covance/Lilly deal may signal a new partnership model for CROs and their pharma clients, but one thing is certain: pharma will continue to outsource and CROs will continue to grow. R&D Directions Senior Editor Michael Christel profiles 11 CROs: Charles River, Covance, Icon, Kendle, MDS, Omnicare, Parexel, PPD, Quintiles, SRI, and UBC. By Michael D. Christel
R&D Business Genentech rejected the initial offer from Roche, but the deal at press time was still alive. By Joseph Gialanella
eR&D New computer-based virtual technologies are predicted to change how pharmaceutical R&D is done in the future. By Joseph Gialanella
Drugs in Development GlaxoSmithKline and Actelion have entered a deal for a new insomnia drug. By Joseph Gialanella
Filed for Approval FDA eliminates approvable and non-approvable letters. By Joseph Gialanella
People on the Move Mark A. Goldberg, M.D., is appointed chief operating officer of Parexel. By Joseph Gialanella
A Game Plan for the Alliance Management Lifecycle The Pharmaceutical and Biotech industry has evolved and become reliant upon a business model dependent on collaborations. The dramatic increase in alliance activity has led to the formation of strategies and organizations focused on how transactions are sourced and managed to enhance product portfolios.
Reach an engaged audience with your brand's message
Download the Med Ad News, R&D Directions, and PharmaLive.com media kit
New
Special Report from PharmaLive.com!
Top 50 Pharmaceutical Companies and Their Pipelines 2008
Today's Health
Today's Health, America's #1 Educational Health Care Television Series, provides an exciting look at the latest innovations in medicine and Healthcare.
Subscribe Now and Save!
Get access to premium content, free PDF reports, and more!
Guide to Contract Research Services
The Guide to Contract Research Services contains in-depth profiles of quality providers of a variety of contract research services. Click here to view advertiser profiles.
The Trend Report
Guideline Inc. has teamed up with Med Ad News to provide the special supplement, Managed Care: Trends in a Slowing Economy
